Immunology

Items 11-20 of 56

per page
Set Descending Direction
  1. Curcumin (high purity)
    CAS  458-37-7
    AG-CN2-0059
    AG-CN2-0059-M01010 mg
    CHF 45.00
    AG-CN2-0059-M05050 mg
    CHF 95.00
    AG-CN2-0059-M250250 mg
    CHF 340.00
    Curcumin (high purity)
  2. Cyclopenin
    CAS  19553-26-5 and 20007-87-8
    AG-CN2-0134
    AG-CN2-0134-M0011 mg
    CHF 150.00
    AG-CN2-0134-M0055 mg
    CHF 600.00
    Cyclopenin
  3. Delanzomib [CEP-18770]
    CAS  847499-27-8
    AG-CR1-3673
    AG-CR1-3673-M0011 mg
    CHF 35.00
    AG-CR1-3673-M0055 mg
    CHF 115.00
    AG-CR1-3673-M02525 mg
    CHF 450.00
    Delanzomib [CEP-18770]
  4. Everolimus
    CAS  159351-69-6
    AG-CN2-0520
    AG-CN2-0520-M0011 mg
    CHF 40.00
    AG-CN2-0520-M0055 mg
    CHF 75.00
    AG-CN2-0520-M02525 mg
    CHF 195.00
    Everolimus
  5. Fc (LALA-PG)-KIH (human):Irisin (monomeric) (rec.)
    AG-40B-0246
    AG-40B-0246-C05050 µg
    CHF 440.00

    Replaces AG-40B-0115

    Fc (LALA-PG)-KIH (human):Irisin (monomeric) (rec.)
  6. FK-506
    CAS  109581-93-3
    AG-CN2-0047
    AG-CN2-0047-M0011 mg
    CHF 20.00
    AG-CN2-0047-M0055 mg
    CHF 35.00
    AG-CN2-0047-M02525 mg
    CHF 140.00
    FK-506
  7. FNDC4 (human) ELISA Kit
    AG-45B-0028
    AG-45B-0028-KI0196 wells
    CHF 610.00
    FNDC4 (human) ELISA Kit
  8. Frizzled-5 (human):Fc (human) (rec.)
    AG-40B-0133
    AG-40B-0133-C05050 µg
    CHF 290.00
    AG-40B-0133-30503 x 50 µg
    CHF 575.00
    Figure: Frizzled-5 (human):Fc (human) (rec.) (AG-40B-0133) efficiently inhibits Wnt3a activation. Methods: Inhibition of Wnt3a activation by Frizzled-5 (human):Fc (human) (rec.) was measured by using HEK293 cells transfected with a plasmid c
  9. Fulvic Acid
    CAS  479-66-3
    AG-CN2-0135
    AG-CN2-0135-M0011 mg
    CHF 170.00
    AG-CN2-0135-M0055 mg
    CHF 680.00
    Fulvic Acid
  10. Fuscin
    CAS  83-85-2
    AG-CN2-0138
    AG-CN2-0138-M0011 mg
    CHF 220.00
    AG-CN2-0138-MM252.5 mg
    CHF 460.00
    Fuscin

Items 11-20 of 56

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.